• About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Menu
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
NEWS
RESOURCES
PODCAST
  • NEWS
  • RESOURCES
  • PODCAST
  • VIDEOS
  • CONTACT
Donate
Subscribe
Search
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Menu
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Evobrutinib does not outperform standard treatment in phase 3 trial 23 April 2025
MS News MS Trials
Evobrutinib does not outperform standard treatment in phase 3 trial
Grand Designs: A builder’s legacy for people with MS 23 April 2025
MS News
Grand Designs: A builder’s legacy for people with MS
Historic breakthrough: First NMOSD treatment added to the PBS 1 April 2025
MS News
Historic breakthrough: First NMOSD treatment added to the PBS
MS Australia 2025 Federal Election Statement 28 March 2025
MS News
MS Australia 2025 Federal Election Statement
From our CEO 25 March 2025
MS News
From our CEO
International Women’s Day – women and MS 7 March 2025
MS News MS Trials
International Women’s Day – women and MS
MS Australia funds a record number of projects targeting MS research priorities 5 March 2025
MS News
MS Australia funds a record number of projects targeting MS research priorities
Have your say in prioritising our MS research and advocacy agenda 28 February 2025
MS Brainbank MS News MS Trials
Have your say in prioritising our MS research and advocacy agenda
From our CEO 26 February 2025
MS News
From our CEO
25 February 2025
MS Brainbank MS News MS Trials
Get Ready for InforMS: Join the AMSLS Today
Load More
MS Australia
registered charity

1300 010 158

info@msaustralia.org.au

Head Office

Suite 3.01, 18 Flour Mill Way
Summer Hill NSW 2130

Participate in MS Research

  • MS Clinical Trials
  • MS Australia Brain Bank
  • Australian MS Longitudinal Study
Facebook-f X-twitter Linkedin-in Youtube Spotify Paper-plane

Quick links

  • What is MS?
  • How is MS diagnosed?
  • COVID-19 and MS
  • Research funding opportunities
  • Research we fund
  • Media enquiries
  • Contact us
© 2025 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
© 2024 Multiple Sclerosis Australia
ABN: 51 008 515 508
Privacy Policy | Whistleblower Policy
Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT

Newsletter subscription

  • Enter your details

Evobrutinib does not outperform standard treatment in phase 3 trial